IPO

Krsnaa Diagnostics Limited IPO

Mainboard

Hospital & Healthcare

Listed On: Aug 16, 2021 at ₹ 1005.55(NSE)

₹ 14310 /15 Shares

Check Allotment

04 Aug, 2021

Open Date

06 Aug, 2021

Close Date

12 Aug, 2021

Allotment Date

16 Aug, 2021

Listing Date
Price Summary

Last Closing

715.60 (-24.99%)

52 Week High

970.00

52 Week Low

625.75

Last Update

19-Dec-2025 3:30 PM
IPO Issue Details
  • Issue Price ₹933-954 per equity share
  • Face Value ₹5 Per Equity Share 
  • Issue Price Total 1211.38 Crores: Fresh Issue: 400 Cr + Offer for Sale: 8,525,520 Shares
  • Listing at BSE, NSE
  • List Price 1005.55(NSE)
  • Listing Date 2021-08-16
  • Lead Manager DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd), Equirus Capital Private Limited, IIFL Holdings Limited, JM Financial Consultants Private Limited
  • Registrar KFintech Private Limited
IPO Details
  • Retail Portion 10%
IPO Documents
IPO Details


The IPO of is priced at ₹933-954 per equity share, which has a face value of ₹5 Per Equity Share  each, IPO bidding starts from Aug 4, 2021 and ends on Aug 6, 2021. The allotment for IPO will be finalized on Aug 12, 2021. IPO will be listed on BSE, NSE, with a tentative listing date fixed as Aug 16, 2021. The company shall list its equity shares on the BSE, NSE. KFintech Private Limited is the registrar of the issue.

The book-running lead manager for the IPO is/are DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd), Equirus Capital Private Limited, IIFL Holdings Limited, JM Financial Consultants Private Limited.


The IPO sets its price band at 933-954 for each share. A single application for Krsnaa Diagnostics Limited IPO must contain at least 15 shares.

Read More
IPO Subscription Analysis And Details
Retail
42.04x
QIB
49.82x
NII
116.29x
Total
64.40x
As on QIB NII Retail Employee Total
Shares Offered / Reserved 37,52,625 18,76,312 12,50,874 2,32,288 71,12,099
Day 1 04-08-21 05:00 PM
0.48 x 0.15 9.59 x 0.21 x 1.98 x
Day 2 05-08-21 05:00 PM
0.51 x 4.71 21.77 x 0.52 x 5.35 x
Day 3 06-08-21 08:00 PM
49.82 x 116.29 42.04 x 0.98 x 64.40 x

Total No of Applications
2966341
Subscription on the basis of Applications
35.57
Valuations
Earnings Per Share (EPS) ₹58.91/-
P/E Ratio 16.19
RoNW 79.76%
Net Asset Value (NAV) - As on 31.03.21 ₹85.27
Company Financials
In Crs.
In Cr.
31-Mar-21 31-Mar-20 31-Mar-19
Assets 604.53 629.98 528.98
Revenue 661.47 271.37 214.31
Profit After Tax 184.92 (111.95) (58.05)
About Company

Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients.

Read More
- Promoter(s)

Rajendra Mutha

Pre Issue Share Holding : 74.63%

Post Issue Share Holding : N/A%

IPO - Issue Objectives
1

To finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh, and Maharashtra.

2

Repayment/pre-payment of firm's borrowings fully or partially.

3

General corporate purposes.

IPO - Anchor Investors

Ahead of IPO, Krsnaa Diagnostics mops up Rs 537 crore from anchor investors
Marquee investors who showed strong interest in the public issue through anchor book were Kuber India Fund, Volrado Venture Partners, HSBC, Tara Emerging Asia Liquid Fund, Societe Generale, Elara India Opportunities Fund, Nomura, Stock Mother Fund, and Segantii India Mauritius.
Among domestic investors, Abakkus Growth Fund, ICICI Prudential, HDFC Life Insurance, SBI Mutual Fund, Tata Mutual Fund, Motilal Oswal Mutual Fund, Edelweiss, Nippon Life, Aditya Birla Sun Life, Kotak Mutual Fund, Max Life Insurance, and Kotak Mahindra Life Insurance also participated in the anchor book.

IPO - Peers Comparison
P/B Ratio P/E Ratio RoNW Revenue(in Cr.)
Krsnaa Diagnostics 11.19 16.19 79.76% 396.46
Metropolis Healthcare 20.52 73.63 27.87% 997.99
Dr. Lalpath Labs 24.34 79.09 30.78% 1,581.27